MOBILEYE GLOBAL INC-A (MBLY)

US60741F1049 - Common Stock

25.66  -0.19 (-0.74%)

After market: 25.66 0 (0%)

Fundamental Rating

5

MBLY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 43 industry peers in the Automobile Components industry. No worries on liquidiy or solvency for MBLY as it has an excellent financial health rating, but there are worries on the profitability. MBLY is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
MBLY had negative earnings in each of the past 5 years.
Each year in the past 5 years MBLY had a positive operating cash flow.

1.2 Ratios

MBLY has a worse Return On Assets (-1.08%) than 64.29% of its industry peers.
MBLY's Return On Equity of -1.12% is in line compared to the rest of the industry. MBLY outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -1.08%
ROE -1.12%
ROIC N/A
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MBLY has a better Gross Margin (48.06%) than 97.62% of its industry peers.
In the last couple of years the Gross Margin of MBLY has grown nicely.
MBLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MBLY has more shares outstanding than it did 1 year ago.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 21.79 indicates that MBLY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 21.79, MBLY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.79
ROIC/WACCN/A
WACC9.35%

2.3 Liquidity

A Current Ratio of 5.87 indicates that MBLY has no problem at all paying its short term obligations.
MBLY's Current ratio of 5.87 is amongst the best of the industry. MBLY outperforms 92.86% of its industry peers.
A Quick Ratio of 4.48 indicates that MBLY has no problem at all paying its short term obligations.
MBLY's Quick ratio of 4.48 is amongst the best of the industry. MBLY outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 5.87
Quick Ratio 4.48

6

3. Growth

3.1 Past

The earnings per share for MBLY have decreased strongly by -55.77% in the last year.
The Revenue has decreased by -3.78% in the past year.
MBLY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.07% yearly.
EPS 1Y (TTM)-55.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Sales Q2Q%-47.82%

3.2 Future

Based on estimates for the next years, MBLY will show a very strong growth in Earnings Per Share. The EPS will grow by 29.26% on average per year.
Based on estimates for the next years, MBLY will show a very strong growth in Revenue. The Revenue will grow by 26.62% on average per year.
EPS Next Y-52.24%
EPS Next 2Y-1.55%
EPS Next 3Y13.32%
EPS Next 5Y29.26%
Revenue Next Year-9.19%
Revenue Next 2Y12.17%
Revenue Next 3Y19.99%
Revenue Next 5Y26.62%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 42.77, the valuation of MBLY can be described as expensive.
MBLY's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of MBLY to the average of the S&P500 Index (27.83), we can say MBLY is valued expensively.
MBLY is valuated quite expensively with a Price/Forward Earnings ratio of 32.68.
66.67% of the companies in the same industry are cheaper than MBLY, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of MBLY to the average of the S&P500 Index (19.84), we can say MBLY is valued expensively.
Industry RankSector Rank
PE 42.77
Fwd PE 32.68

4.2 Price Multiples

MBLY's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 73.81% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MBLY is valued a bit more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 122.44
EV/EBITDA 63.71

4.3 Compensation for Growth

A more expensive valuation may be justified as MBLY's earnings are expected to grow with 13.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.55%
EPS Next 3Y13.32%

0

5. Dividend

5.1 Amount

No dividends for MBLY!.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (5/31/2024, 3:30:01 PM)

After market: 25.66 0 (0%)

25.66

-0.19 (-0.74%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.69B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 42.77
Fwd PE 32.68
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.12%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 48.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.87
Quick Ratio 4.48
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-55.77%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-52.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y29.07%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y